Fact CheckerSign in

NCT07166458Completed

Kefir Peptides for Bone Fracture Healing

Fuctional Assessment of Kefir Fermented Milk on the Improvement of Osteoporosis Combined With Fracture Patient

Source: ClinicalTrials.gov · Last updated 24 Mar 2026

Brief summary (registry, in English)

This study is designed to evaluate the effects of kefir-derived peptides on bone healing in patients with upper limb fractures. Kefir peptides are natural protein fragments that may promote bone formation and reduce inflammation. Participants with recent upper limb fractures will be randomly assigned to receive either kefir peptide supplementation or standard treatment. The main purpose of this study is to determine whether kefir peptides can accelerate bone healing and improve recovery compared to standard care.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
2 Sept 2025
Start date
13 Apr 2020
Primary completion date
20 Jul 2024
Lead sponsor
Jen-Chieh Lai
Diseases
Osteoporosis
NCT number
NCT07166458

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 13 Apr 2020 to the primary completion date, 20 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of medications affecting bone metabolism for more than 4 months, including: glucocorticoids、thyroxine、antiepileptic drugs、bisphosphonates
    • calcitonin、hormone replacement therapy

Other illness

  • History of metabolic or systemic diseases affecting bone metabolism, including: hyperparathyroidism、hyperthyroidism、diabetes mellitus、 hepatic cirrhosis、renal insufficiency

Other

  • Body mass index (BMI) \> 30 kg/m²

Who the study is looking for

  • Bone mineral density T-score ≤ -2.5 measured by dual-energy X-ray absorptiometry (DXA)
  • Acute fragility fracture of the distal radius or proximal humerus, and
  • Postmenopausal women
  • Age ≥ 50 years

Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Chung Hsing University
Coordinator of this site? Confirm its status
TaichungTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.